TFG::ALK fusion in ALK positive large B-cell lymphoma: a case report and review of literature

Anaplastic lymphoma kinase (ALK) positive large B-cell lymphoma (ALK+ LBCL) is an aggressive and rare subtype of B-cell lymphoma. Patients typically present with advanced clinical stage disease and do not respond to conventional chemotherapy; the median overall survival is 1.8 years. The genetic lan...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Andrew, Shahmarvand, Nahid, Nagy, Alexandra, Kumar, Jyoti, Van Ziffle, Jessica, Devine, Patrick, Huang, Franklin, Lezama, Lhara, Li, Peng, Ohgami, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248242/
https://www.ncbi.nlm.nih.gov/pubmed/37305584
http://dx.doi.org/10.3389/fonc.2023.1174606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248242/
https://www.ncbi.nlm.nih.gov/pubmed/37305584
http://dx.doi.org/10.3389/fonc.2023.1174606

Ejemplares similares